May 4, 2010 (Barcelona, Spain) — Monthly infusions of the bisphosphonate zoledronic acid significantly reduce the risk for bone fractures in men with prostate cancer and malignant bone metastases, ...

Former President Joe Biden was diagnosed with an “aggressive form” of prostate cancer that has a five-year survival rate of between 30% and 40%. The former president’s prostate cancer is characterized ...

(iVillage Total Health) - Men who undergo androgen deprivation therapy to treat prostate cancer may be a greater risk of developing gum disease, a new study concluded. The prostate is a walnut-size ...

Former President Joe Biden has been diagnosed with an aggressive form of prostate cancer that has spread to the bone. Last week, a “small nodule” was found on the 82-year-old Biden's prostate after ...

Prostate-specific membrane androgen PET/CT can help clinicians intensify or de-escalate care for men with prostate cancer who have biochemical recurrence following radical prostatectomy.A ...

The American Cancer Society estimates that more than 313,780 cases of prostate cancer will be diagnosed in the United States in 2025, resulting in approximately 35,770 deaths. Bone metastasis - a ...

Prostate cancer is the most common cancer in men throughout the United States. Most men do not realize they have cancer due ...

Hormone-suppressing drugs, increasingly used to treat prostate cancer, make men so prone to broken bones that the risks of the treatment may outweigh the benefits in those whose cancer was caught ...

Erleada plus ADT may provide limited benefits for mCSPC patients with fewer bone metastases, affecting PFS2 and OS outcomes. Baseline bone metastasis count could guide treatment optimization for mCSPC ...

Six-time Olympic gold medalist Sir Chris Hoy recently revealed he has terminal prostate cancer. Amid Hoy’s diagnosis, experts are urging men to keep an eye out for an easy-to-miss sign of prostate ...

LOWCOUNTRY, S.C. (WCIV) — In light of Former President Joe Biden's recent prostate cancer diagnosis, medical professional Dr. David Geier joined "Good Morning Charleston" Monday to discuss the ...

The 2026 European Association of Urology (EAU) annual meeting featured a PARP inhibitors for prostate cancer session and a presentation by Dr. Martin Gleave discussing how to optimize tissue biopsy ...